Newbridge Financial Services Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6
Closed -$43 1274
2023
Q3
$43 Hold
6
﹤0.01% 1261
2023
Q2
$45 Hold
6
﹤0.01% 1318
2023
Q1
$42 Sell
6
-100
-94% -$920 ﹤0.01% 1383
2022
Q4
$1.09K Sell
106
-413
-80% -$7.29K ﹤0.01% 1290
2022
Q3
$9K Hold
519
0.01% 910
2022
Q2
$27K Hold
519
0.02% 564
2022
Q1
$38K Sell
519
-100
-16% -$8.92K 0.02% 548
2021
Q4
$89K Buy
619
+613
+10,217% +$105K 0.04% 340
2021
Q3
$1K Hold
6
﹤0.01% 1288
2021
Q2
$1K Hold
6
﹤0.01% 1374
2021
Q1
$1K Buy
+6
New +$1.2K ﹤0.01% 1299

Other funds holding NVAX

Newbridge Financial Services Group's NVAX Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Novavax (NVAX) in Q4 2023, closing a stake of 6 shares — an estimated $43 sold.

Newbridge Financial Services Group first reported a position in NVAX in Q1 2021 and held it in 11 quarters. The position peaked at $89K in Q4 2021. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 6 Novavax shares in Q4 2023, an estimated $43.
  • Newbridge Financial Services Group first reported a position in Novavax in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's Novavax position peaked at $89K in Q4 2021.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.